Market Signal Briefing

While gold has posted major gains, Bitcoin (BTC) continues to show major signs of weakness, with prices drifting toward lower support levels and now approaching the closely watched $82,000 mark, a pivotal point in determining the next major direction for the world’s largest cryptocurrency.

Against this backdrop, market analyst Doctor Profit has drawn attention to what he describes as one of the most important charts of the current Bitcoin cycle: the Gold‑to‑Bitcoin (GOLD/BTC) ratio. 

What The Gold-To-Bitcoin Ratio Suggests According to Profit, this chart has repeatedly provided reliable signals for major market tops and bottoms. He noted that he first shared this framework nearly a year ago, highlighting a historical pattern in which Bitcoin tends to peak when 0.02 BTC equals one ounce of gold, and bottom when that ratio reaches 0.11 BTC per ounce.

Profit pointed out that this relationship played out during the previous cycle, accurately marking Bitcoin’s top in 2021 and its bottom in 2022. He argues that the same pattern has repeated in the current cycle, claiming Bitcoin’s recent top near $125,000 when the gold‑to‑Bitcoin ratio once again reached the 0.02 level.

GOLD/BTC chart and previous top and bottom patterns. Source: Doctor Profit on X The key question now, he says, is whether the market will again reach the 0.11 BTC‑per‑ounce level that has historically signaled a bottom. Based on current prices, Profit walked through the math. 

Assuming a gold price of roughly $5,500 per ounce, dividing that figure by 0.11 implies a Bitcoin price near $50,000. That outcome, he noted, aligns with his broader expectation that Bitcoin’s cycle low could fall somewhere between $50,000 and $60,000.

He added that even under a more bullish scenario for gold, the analysis still supports his thesis. If gold were to rise to $7,000 per ounce, the same ratio would imply a Bitcoin bottom near $63,000. In his view, both scenarios reinforce the idea that gold is likely to outperform Bitcoin in the coming months.

BTC Nearing Late‑Cycle Bear Phase? Not all analysts, however, share that bearish outlook for Bitcoin. Offering a contrasting perspective, technical analyst Michael van de Poppe suggested that gold’s recent strength could be nearing exhaustion, potentially setting the stage for capital to rotate back into Bitcoin. 

Van de Poppe highlighted the relative strength index (RSI) of Bitcoin measured against gold on the weekly timeframe, noting that it has reached the lowest level ever recorded. 

In his assessment, this suggests a sharp imbalance in valuations, with one asset appearing overextended in the short term and the other deeply undervalued. He described the situation as part of what he calls the “big rotation” phase of the market cycle.

The analyst also pointed to Bitcoin’s Z‑Score indicator, a metric used to assess whether the cryptocurrency is overvalued or undervalued by comparing its market capitalization to its realized capitalization, adjusted for volatility. 

According to van de Poppe, the current Z‑Score for Bitcoin is lower than it was at several major historical bottoms, including those seen in 2015, 2018, the COVID‑19 crash in 2020, and the 2022 bear market low. In his view, this signals that BTC is already deep into a bear‑market phase and may be approaching its final stages. 

The daily chart shows BTC’s price trending downwards. Source: BTCUSDT on TradingView.com At the time of writing, BTC was trading at $83,435, with losses of 2.2% and 7% recorded in the 24-hour and seven-day time frames, respectively. 

Featured image from DALL-E, chart from TradingView.com 

ETH Ethereum Price Prediction

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Simon Chandler

Author

Simon Chandler

Part of the Team Since

Jan 2018

About Author

Simon Chandler is a Brighton-based writer and journalist with over ten years of experience writing about crypto, technology, politics and culture. He has written for Cryptonews.com since late 2017,...

Has Also Written

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Last updated: 

8 minutes ago

The Ethereum price has plunged by 7.5% in the past 24 hours, with its drop to $2,725 coming as disappointing financial reports dragged down stock markets yesterday.

Despite the recent dip, there are reasons to be bullish about ETH, not least because Ethereum ETFs have done a better job in recent days than Bitcoin ETFs in attracting inflows.

They secured $28 million in inflows on Wednesday and $117 million in inflows on Monday, whereas Bitcoin ETFs saw an outflow of $19.6 million and a modest inflow of only $6.8 million.

Ethereum ETF Flow (US$ million) – 2026-01-26

TOTAL NET FLOW: 117

ETHA: -20.2
FETH: 137.2
ETHW: 0
TETH: 0
ETHV: 0
QETH: 0
EZET: 0
ETHE: 0
ETH: 0

For all the data & disclaimers visit:https://t.co/FppgUwAthD

— Farside Investors (@FarsideUK) January 27, 2026 This highlights the greater momentum Ethereum is enjoying at the moment, despite wider market issues, and also suggests that it could outpace Bitcoin (and other tokens) once overall sentiment improves.

When taken with Ethereum’s peerless fundamentals as the biggest layer-one network in crypto, the Ethereum price prediction looks very positive once the current blip is over.

Ethereum Price Prediction: Bitcoin Bleeds, But $28M Just Flooded Into ETH – Is This the Start of the Flippening?As we can see from the Ethereum price chart today, it has just fallen through its medium-term support level of $2,750, something which may spell further losses in the near term.

Its technical indicators have also plunged in recent days, yet are not quote at a bottom/

Source: TradingViewIts relative strength index (yellow) is dropping towards 30, but we may not see the Ethereum price stabilize until it gets closer to 20.

Likewise, ETH’s MACD (orange, blue) fell below 0 a few days ago, but it still hasn’t plumbed the lows we saw in mid-to-late November.

In other words, the Ethereum price could drop even lower in the coming days, perhaps sliding to $2,500 – which would be its lowest level since June 2025 – before bouncing back up.

This is what some traders and analysts are already predicting, although they also believe that ETH shouldn’t fall any further than this.

And once it has bottomed out at around $2,500, it could regain $2,750 and then $3,000 by the end of Q1.

From there, it could pass $4,000 by H2 and then end the year closer to $7,000.

SUBBD Presale Lets Users Earn Crypto with Artificial IntelligenceAs enormously strong as Ethereum remains, there are other, newer alts investors may want to diversify into, in order to widen their exposure to potential gains.

Several promising coins right now happen to be holding their presales, with one of the most interesting of these being new ERC-20 token SUBBD ($SUBBD).

SUBBD has raised more than $1.4 million in its ongoing sale, with investors gaining confidence in its plans to launch an AI-powered content creation platform.

Its platform will provide creators with AI tools that can help them generate not only images and videos, but also AI agents that will star in their content.

This has the potential to make creators much more productive, something which could give SUBBD an edge over its competition.

Investors can join the sale on the SUBBD website, where the token is currently priced at $0.057485.

Visit the Official SUBBD Website Here

  Rouyn Noranda, Q.C., January 30, 2026 – TheNewswire - Granada Gold Mine Inc. (TSXV: GGM) (OTC: GBBFF) (Frankfurt: B6D) (the "Company" or "Granada") is pleased to announce a non-brokered private placement offering raising gross proceeds of  up to $2.500,000 through the issuance of up to 50,000,000 units (the "Units") at a price of $0.05 per Unit (the "Offering").

  Each Unit is comprised of one common share of the Company (each, a "Common Share") and one Common Share purchase warrant ( the "Warrants") of the Company. Each Warrant entitling the holder thereof to purchase one Common Share at a price of $0.075 per Common Share for a period of five (5) years from the date of issuance.

  The Company may pay finders' fees in connection with the Offering to eligible arm's length finders in accordance with applicable securities laws and the policies of the TSXV.

  The Company intends to use net proceeds of the offering for a resource update, exploration and general corporate purposes for the Company’s Granada Gold Property, near Rouyn-Noranda, Quebec.

  All securities issued in connection with the private placement will be subject to a four‐month and a

day hold period in accordance with applicable Canadian Securities Laws.

  Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.

  This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements thereunder.

  Qualified person

  The technical information in this news release was reviewed and approved by Matthew Halliday, P.Geo., Director of Granada Gold Mine Inc., and member of the Ordre des Géologues du Québec, who is a Qualified Person in accordance with National Instrument 43-101.

  Mineral Resource Estimate

  On August 22, 2022 the Company filed an updated NI 43-101 technical report supporting the resource estimate update for the Granada Gold project (Please see July 6, 2022 news release) reporting that the Granada deposit contains an updated mineral resource, at a base case cut-off grade of 0.55 g/t Au for pit constrained mineral resources within a conceptual pit shell and at a base case cut-off grade of 2.5 g/t for underground mineral resources within reasonably mineable volumes, of 543,000 ounces of gold (8,220,000 tonnes at an average grade of 2.05 g/t Au) in the Measured and Indicated category, and 456,000 ounces of gold (3,010,000 tonnes at an average grade of 4.71 g/t Au) in the Inferred category. Please see Table 1 below for full details. Report reference: Granada Gold Project Mineral Resource Estimate Update, Rouyn-Noranda, Quebec, Canada authored by Yann Camus, P.Eng. and Maxime Dupéré, B.Sc, P.Geo., SGS Canada Inc. dated August 20th, 2022 and with an effective date of June 23rd, 2022.

  Table 1: Mineral Resource Estimate Showing Tonnes, Average Grade, and Gold Ounces

  Cut-Off

(g/t Au)

Classification

Type

Tonnes

Au (g/t)

Gold Ounces

0.55 / 2.5

Measured1

InPit+UG

4,900,000

1.70

269,000

  Indicated

InPit+UG

3,320,000

2.57

274,000

  Measured & Indicated

InPit+UG

8,220,000

2.05

543,000

  Inferred

InPit+UG

3,010,000

4.71

456,000

  About Granada Gold Mine Inc.

  Granada Gold Mine Inc. continues to develop and explore its 100% owned Granada Gold Property near Rouyn-Noranda, Quebec, and is adjacent to the prolific Cadillac Break. The Company owns 14.73 square kilometers of land in a combination of mining leases and claims. The Company is currently undergoing a large drill program with 20,000m out of 120,000m complete. The drills are currently paused to provide the technical team with the necessary time to evaluate, assimilate existing data and wait for improved market conditions. 

  The Granada Shear Zone and the South Shear Zone contain, based on historical detailed mapping as well as from current and historical drilling, up to twenty-two mineralized structures trending east-west over five and a half kilometers. Three of these structures were mined historically from four shafts and three open pits. Historical underground grades were 8 to 10 grams per tonne gold from two shafts down to 236 m and 498 m with open pit grades from 3.5 to 5 grams per tonne gold.

  The property includes the former Granada Gold underground mine which produced more than 50,000 ounces of gold at 10 grams per tonne gold in the 1930’s from two shafts before a fire destroyed the surface buildings.  In the 1990s, Granada Resources extracted a bulk sample (Pit #1) of 87,311 tonnes grading 5.17 g/t Au.  They also extracted a bulk sample (Pit # 2) of 22,095 tonnes grading 3.46 g/t Au.  

    For further information, Contact:

Frank J. Basa, P.Eng. member of Professional Engineers Ontario

Chief Executive Officer

P: 416-625-2342

  Or:

  Wayne Cheveldayoff, 

Corporate Communications

P: 416-710-2410 

E: [email protected]

  Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking statements which include, but are not limited to, comments that involve future events and conditions, which are subject to various risks and uncertainties. Except for statements of historical facts, comments that address resource potential, upcoming work programs, geological interpretations, receipt and security of mineral property titles, availability of funds, and others are forward-looking. Forward-looking statements are not guarantees of future performance and actual results may vary materially from those statements. General business conditions are factors that could cause actual results to vary materially from forward-looking statements. The Company does not undertake to update any forward-looking information in this news release or other communications unless required by law.

  

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

High Tide Inc. (HITI:CA) Q4 2025 Earnings Call January 30, 2026 11:30 AM EST

Company Participants

Omar Khan - Chief Communications & Public Affairs Officer
Harkirat Grover - Founder, CEO, President & Executive Chairman
Mayank Mahajan - Chief Financial Officer

Conference Call Participants

Neal Gilmer - Haywood Securities Inc., Research Division
Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division
William Kirk - ROTH Capital Partners, LLC, Research Division
Michael Kim - Zacks Small-Cap Research
Houpeng Zhu - Canaccord Genuity Corp., Research Division

Presentation

Operator

Good morning. My name is Constantine, and I'll be your conference operator today.

At this time, I would like to welcome everyone to High Tide Inc.'s Fourth Fiscal Quarter 2025 Audited Financial and Operational Results Conference Call.

[Operator Instructions]

I will now turn the call over to your host.

Omar Khan
Chief Communications & Public Affairs Officer

Thank you, operator. Good morning, everyone. My name is Omar Khan, I'm the Chief Communications and Public Affairs Officer for High Tide Inc. Welcome High Tide's quarterly earnings call.

Joining me on the call today are Mr. Raj Grover, President and Chief Executive Officer; and Mr. Mayank Mahajan, Chief Financial Officer.

On January 29, 2026, the company released financial and operational results for the fiscal year and quarter that ended October 31, 2025.

Before we begin, please let me remind you that during the course of this conference call, High Tide's management may make statements, including with respect to management's expectations or estimates of future performance. All such statements other than statements of historical facts constitute forward-looking information or forward-looking statements within the meaning of the applicable securities laws and are based on assumptions, expectations, estimates and projections as of the date, hereof.

Specific forward-looking statements include, without limitation, all disclosures regarding future results of operations, economic conditions and anticipated courses of action. For more

, /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, showcased a series of groundbreaking AI products at Spielwarenmesse 2026 in Nuremberg from January 27 to 31. At the event, Tuya also unveiled the secret behind the next generation of AI toys that are set to become the next big hit.

Nebula Plush AI Toy

The most impressive feature of the Nebula Plush AI Toy is its real-time LED facial expression feedback based on user emotions. When you're happy or sad, it can respond through changes in its eyes. It not only supports smooth conversation but also features carefully designed tactile feedback, responding to hugs and touches vividly. Combined with storytelling, news broadcasting, and interactive games, it becomes a true AI companion with long-term memory and emotional companionship capabilities.

Walulu

Walulu precisely addresses the demand for personalized companionship. Its AI core can detect up to 19 distinct emotional responses and supports over 60 languages. Moreover, it integrates seamlessly with major AI large language models, including ChatGPT, Gemini, DeepSeek, Qwen, and Doubao. Users can choose or cultivate a range of personality traits—such as cheerful, quiet, curious, or considerate—to build a personalized, dynamic pet community.

AI Learning Camera

The AI Learning Camera skillfully blends AI vision with education. Its object recognition feature not only identifies objects but also links them to cultural and educational content. For example, when capturing foreign languages, the camera can provide real-time pronunciation and translation. Additionally, its built-in AI filters and image transformation features can turn children's doodles into stunning digital artwork, igniting creativity. Through multimodal AI conversations, it can also become a fun, exploratory companion for children as they discover the world.

In addition, Tuya showcased AI robotic dogs with motion mimicry and emotional interaction capabilities, responding to voice commands and performing a variety of realistic actions. There was also the AI Clock, offering customizable theme scenes and alarm settings that turn every wake-up into a ceremonial experience. These innovative AI products represent the expanding boundaries of intelligent companionship. They demonstrate that the next generation of AI toys is moving beyond single-function toys to offer deeper emotional resonance, more personalized interactive experiences, and seamless integration with real-world scenarios.

Tuya AI Toy Solution: The Foundation Behind Hot-Selling Products

Developing truly intelligent AI toys is no easy task. From hardware design and AI model training to multilingual support and content safety, every step presents a unique challenge. To empower developers, brands, and retailers to create the next generation of AI toys, Tuya Smart introduced its comprehensive AI toy solution at the Spielwarenmesse 2026. The solution spans the entire process—from concept design and hardware/software development to AI personality creation and market launch—dramatically reducing the development and application barriers for AI toys.

Transform Toys to AI Companions

Using Tuya's AI Agent Development Platform, customers can design the personality, memory logic, and behavioral patterns of their toys without having to train underlying models or build complex infrastructure. The platform seamlessly integrates with leading AI models, enabling multi-turn conversations, emotional feedback, and scenario-based memory, effectively transforming static toys into intelligent, responsive companions that can connect more deeply with users.

Flexible AI Toy Development Tailored to Every Client

Tuya offers several development pathways to meet the various needs of brand owners and retailers. Clients can choose from ready-to-market OEM solutions, integrate AI capabilities into existing products through Tuya's AI Modules and AI Boxes while maintaining their original design, or opt for deep customization to craft unique AI toys based on brand IP and cultural stories. Whether it's plush toys, robots, educational tools, or wearable tech, Tuya's AI toy solutions offer the most appropriate options.

Responsible Companionship Designed for Families in the AI Era

Data privacy and content security are critical when it comes to children. Tuya's AI toy solutions are equipped with a parental management app, enabling parents to monitor conversation histories, receive AI-generated behavior summaries, and gain growth insights. Parents can also manage interaction content and screen time, ensuring a responsible and secure AI companionship experience for families.

Enabling Client Success Through Efficient AI Toy Deployment

In the wave of AI toy innovation, Tuya provides developers, brand owners, and retailers with a faster, more cost-effective, and secure path to market. With Tuya's robust AI platform and module support, customers can bypass the complexity of building AI from scratch, reducing the development cycle from concept to mass production by more than 60%. The time to market can be as short as 15 days, enabling a fast track for launching new products.

Cost-wise, Tuya's integrated AI platform minimizes repetitive development and integration costs, leading to a 30% to 50% reduction in overall R&D and implementation expenses. On the security and compliance front, the platform is pre-configured with security frameworks that adhere to global standards like GDPR and CCPA, supporting hardware encryption, data localization, and parental controls to help products enter global markets swiftly.

Additionally, Tuya's AIoT infrastructure spans over 200 countries and regions, offering real-time language support in more than 60 languages and robust cloud management capabilities, enabling efficient global deployment and operations.

As AI continues to evolve, the true value of toys lies not just in their "intelligence" but in how they foster emotional connections and support growth. At the Spielwarenmesse 2026, Tuya's showcase was more than just a presentation—it was a deeper conversation about the future of AI and emotional companionship. Looking ahead, Tuya will continue to partner with global innovators to explore the future of AI toys, creating truly warm companions for the next generation.

SOURCE Tuya Smart

January 30, 2026 17:04 ET  | Source: WestBond Enterprises Corporation

DELTA, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- WestBond Enterprises Corporation (TSX-V: WBE) is pleased to announce that the net profit for the quarter ended December 31, 2025 increased 24.8% to $217,948 when compared to a profit of $174,630 for the three months ended September 30, 2025. Sales were $2,973,050 for the quarter ended December 31, 2025, which is 1.9% lower than $3,030,669 for the quarter ended September 30, 2025.

On the hospitality/domestic side, we continue to supply customized air-laid napkins to high-profile national restaurant chains. An additional major restaurant chain has committed to our napkins and orders have already been received. Demand for our products remains high and we continue to rebrand our products to aid in our marketing efforts, which includes a proposed expansion into the retail sector.

After four years in her role, Ms. Subhashni Prasad has resigned as the Secretary/Treasurer and Chief Financial Officer of the Company, effective January 30, 2026, to pursue other opportunities. The Board would like to thank Ms. Prasad and wish her well in her future endeavors. Mr. Owen Granger, who retired as a Director, Secretary/Treasurer and Chief Financial Officer of the Company in December 2021, has been re-engaged as a consultant to assist in the selection of a new CFO.

The quarterly report and other information are available on the company’s website at www.westbond.ca and on SEDAR+ at www.sedarplus.com.

For further information please contact:

Gennaro Magistrale

Chief Executive Officer, President and Director
WestBond Enterprises Corporation
101 – 7403 Progress Way, Delta, B.C. V4G 1E7

Tel: (604) 940-3939

Cautionary Note Regarding Forward Looking Statements: This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the Company’s intentions. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should” or “would” occur. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the ability to sustain or develop markets and increase profitability. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, changes in operating performance, availability of and prices for raw materials, availability of trained labour, foreign currency exchange rate fluctuations, unexpected competition, trade restrictions and other technical, market and economic factors. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that is incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbour.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Valley National Bancorp: Poised For Growth After Transformation (Upgrade)

January 30, 2026 17:06 ET  | Source: Reflex Advanced Materials Corp.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (FSE:HF2) (“Reflex” or the “Company”) is pleased to announce that it has closed its previously announced non-brokered private placement offering of units of the Company (“Units”), at a price of C$0.175 per Unit, for aggregate gross proceeds of C$199,925. Each Unit is comprised of one common share of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder to acquire one Share (each, a “Warrant Share”) at a price of C$0.23 for a period of 24 months.

The Company intends to use the net proceeds raised from the Offering for working capital and general corporate purposes. All securities issued in the Offering are subject to a four month and one day hold period.

The securities issued pursuant to the Offering have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons in the absence of U.S. registration or an applicable exemption from the U.S. registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

About Reflex Advanced Materials Corp.

Reflex Advanced Materials Corp. is a mineral exploration company based in British Columbia. Its objective is to locate and, if warranted, develop economic mineral properties in the strategic metals and advanced materials space. It is focused on improving domestic specialty mineral infrastructure efficiencies to meet surging national demand by North American manufacturers.

For more information, please review the Company's filings available at www.sedarplus.ca and visit the Company's website at www.reflexmaterials.com.

ON BEHALF OF THE COMPANY

DJ Bowen
Interim CEO & Director

Reflex Advanced Materials Corp.
Suite 915 - 700 West Pender Street
Vancouver, BC V6C 1G8 Canada
Tel: (778) 837-7191
Email: [email protected]

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the proposed use of proceeds therefrom and the Company's business prospects, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, availability of capital, and changes in general economic, market and business conditions, and timely receipt of all necessary regulatory and other approvals. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.

January 30, 2026 17:10 ET  | Source: Elcora Advanced Materials Corp.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

HALIFAX, Nova Scotia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V: ERA | Frankfurt: ELM0 | OTCQB: ECORF), (the "Company" or "Elcora"), is pleased to announce that it has closed a second tranche (the “Second Tranche”) of its private placement pursuant to a price reservation Form 4A (“Form 4A”) filed with the TSX Venture Exchange on December 29, 2025 (see news release dated January 23, 2026). The Company issued 10,591,666 units at a price of $0.12 per Unit for gross proceeds of approximately $1,271,000 for the Second Tranche.

As announced on January 23, 2026, the Company issued 8,158,333 units at a price of $0.12 per Unit for gross proceeds of approximately $979,000 for the first tranche (the “First Tranche”). Accordingly, upon completion of the Second Tranche, the Company has issued a combined total of 18,749,999 Units at $0.12 and raised combined total gross proceeds of approximately $2,250,000.

Pursuant to the Form 4A, the Company may issue up to 25,000,000 Units at $0.12 per unit (the “Units”) to raise total gross proceeds of up to $3,000,000 (the “Offering”).   Each Unit will consist of one (1) common share and one (1) share purchase warrant (a “Warrant”). Each Warrant will be exercisable for an additional share at a price of $0.16 for a period of twenty-four (24) months from issuance.

One of the Company’s Directors participated in the Offering and acquired 1,183,334 Units in the First Tranche and an additional 816,667 Units in the Second Tranche, for total gross proceeds of approximately $240,000. The participation by insiders in the Offering is considered to be a “related party transaction” as defined under Multilateral Instrument 61-101 (“MI 61- 101”).  The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities being issued nor the consideration being paid exceeds 25% of the Company’s market capitalization.

No finders’ fees were paid and no new insider or control person was created. The Company intends to use the net proceeds for general working capital purposes. All securities issued pursuant to the offering will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws. Closing of the Offering is subject to receipt of all necessary regulatory approvals and final acceptance by the TSX Venture Exchange.

About Elcora Advanced Materials Corp.

Elcora was founded in 2011 and has been structured to become a vertically integrated battery material company. Elcora can process, refine, and produce battery related minerals and metals. As part of the vertical integration strategy Elcora has developed a cost-effective process to purify high-quality battery metals and minerals that are commercially scalable. This combination means that Elcora has the tools and resources for vertical integration of the battery minerals and metals industry.

For further information please visit the company's website at:

http://www.elcoracorp.com 

For further information please contact: Troy Grant, Director, President & CEO, Elcora Advanced Materials Corp., T: +1 902 802-8847

CAUTIONARY STATEMENT:

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.  Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock Exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.  

This News Release includes certain “forward-looking statements”. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding potential mineralization and reserves, exploration results, and future plans and objectives of Elcora, are forward-looking statements that involve various risks and uncertainties.  There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.  Important factors that could cause actual results to differ materially from Elcora’s expectations are exploration risks detailed herein and from time to time in the filings made by Elcora with securities regulators.

Investors are cautioned that, except as disclosed in the filing statement prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon.

Elekta AB (publ) (EKTAY) Shareholder/Analyst Call January 30, 2026 8:00 AM EST

Company Participants

Peter Nyquist - Head of Investor Relations
Jakob Just-Bomholt - CEO & President
Christopher Busch - Chief Product & Technology Officer
Anming Gong
Ardie Ermers

Conference Call Participants

Jonathon Unwin - Barclays Bank PLC, Research Division
Veronika Dubajova - Citigroup Inc., Research Division
Richard Felton - Goldman Sachs Group, Inc., Research Division
Erik Cassel - Danske Bank A/S, Research Division
Sten Gustafsson - ABG Sundal Collier Holding ASA, Research Division
Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division
Kavya Deshpande - UBS Investment Bank, Research Division
Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division

Presentation

Peter Nyquist
Head of Investor Relations

Good afternoon, everyone, and a warm welcome to today's strategy update presentation by Elekta. My name is Peter Nyquist, and I'm Head of Investor Relations at Elekta. With me here in different time zones around the world, I have Jakob, our CEO, in the studio here in Stockholm. In Cawley, just outside London, we have Christopher Busch, Chief Product and Technology Officer. And in Beijing, China, we have Anming Gong, Head of the region China. And finally, we have our Head of North America, Ardie Ermers speaking from Atlanta U.S.

So today, we will talk about 4 priorities. We call them must-win battles. The first one, Simplify, Empower and Speed. That was one we presented actually as we report our Q2 numbers. And today, we will go mere into how we established our new operating model and talk about the SEK 500 million in yearly savings that generated from that new operating model. But we will also present further 3 must-win battle. One is focused innovation; the second one is win in the U.S. and expand in China; and the third one is continuous COGS reduction.

Today, the presentation will not include any new financials. We will

Extraordinary General Meeting of Shareholders to Approve Business Combination Scheduled for February 27, 2026  

Fort Worth, TX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. (NYSE: FTW) (“EQV”), a special purpose acquisition company sponsored by EQV Group, and Presidio Investment Holdings LLC (“Presidio”), a differentiated oil and gas operator focused on the optimization of mature, producing oil and natural gas assets in the United States, today announced that EQV’s registration statement on Form S-4 relating to the previously announced business combination between EQV and Presidio (the “Business Combination”) has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”).

EQV will mail the definitive proxy statement/prospectus (the “Proxy Statement/Prospectus”) to shareholders of record as of the close of business on January 30, 2026. The Proxy Statement/Prospectus contains a proxy card relating to the extraordinary general meeting of EQV’s shareholders (the “Extraordinary General Meeting”).

The Extraordinary General Meeting to approve the proposed Business Combination is scheduled to be held on February 27 at 8.00 a.m. Central Time via a virtual meeting format at www.virtualshareholdermeeting.com/FTW2026SM. If the proposals at the Extraordinary General Meeting are approved, the parties anticipate that the Business Combination will close and the combined entity will trade on the New York Stock Exchange under the ticker symbol “FTW” shortly thereafter, subject to the satisfaction or waiver, as applicable, of all other closing conditions.

“Congratulations to all our stakeholders on this important milestone as we approach completion of our Business Combination. We look forward to closing the transaction and implementing our PDP-focused dividend yield acquisition platform. As we disclosed in our recent investor presentation, our backlog of potential acquisition targets has increased to $15 billion. These prospective targets align with our investment criteria, including driving dividend growth,” said Will Ulrich, Co-Founder and Co-CEO of Presidio.

Jerry Silvey, Founder and CEO of EQV, added, "We are excited to reach this critical step in bringing Presidio to the public markets. Presidio's proven track record of acquiring and optimizing producing oil and gas assets positions the company to return capital to shareholders at an attractive rate while executing its growth strategy."

Every shareholder's vote is important, regardless of the number of shares held. Accordingly, EQV requests that each shareholder complete, sign, date and return a proxy card (online or by mail) as soon as possible, which must be received no later than 11:59 p.m. Eastern Time on February 26, 2026, to ensure that the shareholder's shares will be represented at the Extraordinary General Meeting. Shareholders who hold shares in “street name” (i.e. those shareholders whose shares are held of record by a broker, bank or other nominee) should contact their broker, bank or nominee to ensure that their shares are voted.

If any EQV shareholder does not receive the Proxy Statement/Prospectus, such shareholder should (i) confirm his or her Proxy Statement/Prospectus’ status with his or her broker or (ii) contact Sodali & Co., EQV's proxy solicitor, for assistance via e-mail at [email protected] or toll-free call at (800) 662-5200. Banks and brokers can place a collect call to Sodali & Co. at (203) 658-9400.

About Presidio

Headquartered in Fort Worth, TX, Presidio is a leading operator of mature oil and gas wells across the Mid-Continent. The company is focused exclusively on optimizing existing production and generating sustainable cash flow from low-decline, producing assets. To learn more about Presidio, please visit https://bypresidio.com/.

About EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp. (NYSE: FTW) is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. EQV’s sponsor is an affiliate of EQV Group, which was formed in 2022 and is an active acquirer and operator of proved developed producing oil and gas properties, and currently owns and operates more than 3,500 wells across 10 states.

Forward-Looking Statements

This press release includes “forward-looking statements.” These include EQV’s, Presidio Pubco Inc’s (“Pubco”), EQVR’s or Presidio’s or their management teams’ expectations, hopes, beliefs, intentions or strategies regarding the future. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “potential,” “budget,” “may,” “will,” “could,” “should,” “continue” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Pubco’s, Presidio’s, EQVR’s and EQV’s expectations with respect to future performance, the capitalization of EQV or Pubco after giving effect to the proposed Business Combination and expectations with respect to the future performance and the success of Pubco following the consummation of the proposed Business Combination. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Pubco’s, Presidio’s, EQVR’s and EQV’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied upon by any investors as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Pubco, Presidio, EQVR and EQV. These forward-looking statements are subject to a number of risks and uncertainties, including changes in business, market, financial, political and legal conditions; benefits from hedges and expected production; the inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that any regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect Pubco or the expected benefits of the proposed Business Combination or that the approval of the shareholders of EQV is not obtained; failure to realize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, competition, the ability of Pubco to grow and manage growth profitably, maintain key relationships and retain its management and key employees; risks related to the uncertainty of the projected financial information with respect to Presidio or Pubco; risks related to Presidio’s current growth strategy; the occurrence of any event, change or other circumstances that could give rise to the termination of any definitive agreements with respect to the proposed Business Combination; the outcome of any legal proceedings that may be instituted against any of the parties to the potential Business Combination following its announcement and any definitive agreements with respect thereto; changes to the proposed structure of the proposed Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the proposed Business Combination; risks that Presidio or Pubco may not achieve their expectations; the ability to meet stock exchange listing standards following the proposed Business Combination; the risk that the proposed Business Combination disrupts the current plans and operations of Presidio; costs related to the potential Business Combination; changes in laws and regulations; risks related to the domestication of EQV as a Delaware corporation; risks related to Pubco’s ability to pay expected dividends; the extent of participation in rollover agreements; the amount of redemption requests made by EQV’s public equity holders; and the ability of EQV or Pubco to issue equity or equity-linked securities or issue debt securities or enter into debt financing arrangements in connection with the proposed Business Combination or in the future. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Presidio, EQV, EQVR or Pubco resulting from the proposed Business Combination with the SEC, including under the heading “Risk Factors” in the Registration Statement. If any of these risks materialize or any assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that none of Pubco, Presidio, EQVR nor EQV presently know or that Pubco, Presidio, EQVR or EQV currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by investors as a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

In addition, forward-looking statements reflect Pubco’s, Presidio’s, EQVR’s and EQV’s expectations, plans or forecasts of future events and views as of the date they are made. Pubco, Presidio, EQVR  and EQV anticipate that subsequent events and developments will cause Pubco’s, Presidio’s, EQVR’s and EQV’s assessments to change. However, while Pubco, Presidio, EQVR and EQV may elect to update these forward-looking statements at some point in the future, Pubco, Presidio, EQVR and EQV specifically disclaim any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Pubco’s, Presidio’s, EQVR’s or EQV’s assessments as of any date subsequent to the date they are made. Accordingly, undue reliance should not be placed upon the forward-looking statements. None of Pubco, Presidio, EQVR or EQV, or any of their respective affiliates have any obligation to update these forward-looking statements other than as required by law.

Additional Information and Where to Find It

In connection with the proposed Business Combination, Pubco, EQVR and Presidio filed the Registration Statement with the SEC, which includes a prospectus with respect to Pubco’s securities to be issued in connection with the proposed Business Combination and a proxy statement with respect to the shareholder meeting of EQV to vote on the proposed Business Combination. EQV, Pubco, EQVR and Presidio also plan to file other documents and relevant materials with the SEC regarding the proposed Business Combination. The Registration Statement was declared effective by the SEC on January 30, 2026. Mailing of the definitive Proxy Statement/Prospectus to EQV’s shareholders of record as of January 30, 2026 commenced on January 30, 2026. The Proxy Statement/Prospectus includes information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to EQV’s shareholders in connection with the proposed Business Combination. SECURITY HOLDERS OF EQV AND OTHER INTERESTED PARTIES ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER DOCUMENTS AND RELEVANT MATERIALS RELATING TO THE PROPOSED BUSINESS COMBINATION THAT HAVE BEEN AND WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BEFORE MAKING ANY VOTING DECISION WITH RESPECT TO THE PROPOSED BUSINESS COMBINATION BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS COMBINATION AND THE PARTIES TO THE PROPOSED BUSINESS COMBINATION. Shareholders are able to obtain free copies of the Proxy Statement/Prospectus and other documents containing important information about Pubco, Presidio, EQVR and EQV once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. In addition, the documents filed by EQV may be obtained free of charge from EQV at www.eqvventures.com. Alternatively, these documents, when available, can be obtained free of charge from EQV or Pubco upon written request to EQV Ventures Acquisition Corp., 1090 Center Drive, Park City, Utah, 84098, Attn: Secretary, or by calling (405) 870-3781. The information contained on, or that may be accessed through the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.

Participants in the Solicitation

EQV, Presidio, EQVR, Pubco and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of EQV in connection with EQV’s shareholder meeting. Security holders may obtain more detailed information regarding the names, affiliations and interests of certain of EQV’s executive officers and directors in the solicitation by reading EQV’s annual report on Form 10-K, filed with the SEC on March 31, 2025, the definitive Proxy Statement/Prospectus, filed with the SEC on January 30, 2026, the Registration Statement and other relevant materials filed with the SEC in connection with the proposed Business Combination when they become available. Information concerning the interests of EQV’s participants in the solicitation, which may, in some cases, be different from those of EQV’s shareholders generally, is set forth in the definitive Proxy Statement/Prospectus and the Registration Statement.

No Offer or Solicitation

This press release shall not constitute a solicitation of any proxy, vote, consent or approval in any jurisdiction in connection with the proposed Business Combination and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of EQV, PIH, EQVR or Pubco, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended. This press release is restricted by law; it is not intended for distribution to, or use by any person in, any jurisdiction in where such distribution or use would be contrary to local law or regulation.

Pubco Media and Investor Contact:

[email protected]

For EQV:

[email protected] 

Source: EQV Ventures Acquisition Corp.

January 30, 2026 17:15 ET  | Source: Enzon Pharmaceuticals, Inc

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that it has commenced an exchange offer (the “Offer”) involving its Series C Non-Convertible Redeemable Preferred Stock (the “Series C Preferred Stock”) identified in the Prospectus/Consent Solicitation/Offer to Exchange (as defined below) in connection with Enzon’s previously announced merger with Viskase Companies, Inc. (“Viskase”).

What’s Being Offered

Enzon is offering all holders of outstanding shares of Series C Preferred Stock the chance to exchange their shares for shares of Enzon’s common stock, par value $0.01 per share (the “Common Stock”). Each share of Series C Preferred Stock can be exchanged for an amount of Common Stock equal to (i) the aggregate liquidation preference of each share of Series C Preferred Stock, divided by (ii) $7.83 after giving effect to the Reverse Stock Split (as defined in the Prospectus/Consent Solicitation/Offer to Exchange, dated January 28, 2026 (the “Prospectus/Consent Solicitation/Offer to Exchange”)).

Key Dates and Information

Deadline to Participate: The offer expires at one minute after 11:59 p.m., Eastern Time, on Friday, February 27, 2026, unless extended.Holders of Series C Preferred Stock who elect to participate in the Offer can withdraw their tendered shares any time before the deadline. Offer Details

The Offer is described in full in the Prospectus/Consent Solicitation/Offer to Exchange, filed with the U.S. Securities and Exchange Commission on January 28, 2026, and the Schedule TO (as defined below), filed with the U.S. Securities and Exchange Commission on January 30, 2026.

Common Stock Symbol: ENZN (quoted on the “OTCQB” tier of the OTC market)Preferred Stock: Not publicly traded; 40,000 shares outstanding as of January 30, 2026 HKL & Co., LLC has been appointed as the Information Agent for the Offer, and Continental Stock Transfer & Trust Company has been appointed as the Exchange Agent. Requests for documents should be directed to HKL & Co., LLC at +1 (800) 326-5997 (for individuals) or +1 (212) 468-5380 (for banks and brokers) or via the following email address: [email protected].

About Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc., together with its subsidiary, is positioned as a public company acquisition vehicle, that has sought to become an acquisition platform.

Important Additional Information Has Been Filed with the SEC

The Offer commenced on January 30, 2026. On January 28, 2026, a registration statement on Form S-4 and preliminary prospectus included therein and an exchange offer statement on Schedule TO (the “Schedule TO”), including an offer to exchange, a letter of transmittal and consent and related documents, were filed with the SEC by the Company. The offer to exchange the outstanding shares of Series C Preferred Stock of the Company will only be made pursuant to the Prospectus/Consent Solicitation/Offer to Exchange and Schedule TO, including related documents filed as a part of the Offer. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROSPECTUS/CONSENT SOLICITATION/OFFER TO EXCHANGE AND SCHEDULE TO FILED OR TO BE FILED WITH THE SEC CAREFULLY, AS THEY MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND SECURITY HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING THE EXCHANGE OFFER, INCLUDING THE TERMS AND CONDITIONS OF THE EXCHANGE OFFER. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to HKL & Co., LLC at +1 (800) 326-5997 (for individuals) or +1 (212) 468-5380 (for banks and brokers) or via the following email address: [email protected]. Investors and security holders may also obtain, at no charge, the documents filed or furnished to the SEC by the Company under the “Investors” section of the Company’s website at https://investor.enzon.com/.

No Offer or Solicitation

This press release shall not constitute an offer to exchange or the solicitation of an offer to exchange or the solicitation of an offer to purchase any securities, nor shall there be any exchange or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Offer is being made only through the Schedule TO and Prospectus/Consent Solicitation/Offer to Exchange, and the complete terms and conditions of the Offer are set forth in the Schedule TO and Prospectus/Consent Solicitation/Offer to Exchange.

None of the Company, any of its management or its board of directors, or the Information Agent or the Exchange Agent makes any recommendation as to whether or not holders of shares of Series C Preferred Stock should tender shares of Series Preferred Stock for exchange in the Offer.

Forward-Looking Statements

Certain statements contained in this filing may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the proposed transaction involving Enzon and Viskase, the ability to consummate the proposed transaction, the ability to consummate the Offer, the timing of the Expiration Date, and the ability to quote the common stock of the combined company on the “OTCQB” tier of the OTC market of the OTC Markets Group, Inc. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to obtain the necessary approvals for the proposed transaction; (ii) uncertainties as to the timing of the consummation of the proposed transaction, including timing for satisfaction of the closing conditions, and the ability of each of Enzon and Viskase to consummate the proposed transaction; (iii) the ability of Viskase to timely deliver the financial statements required by the Merger Agreement, as amended; (iv) the possibility that other anticipated benefits of the proposed transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the combined company’s operations, and the anticipated tax treatment of the combination; (v) potential litigation relating to the proposed transaction that could be instituted against Enzon, Viskase or their respective officers or directors; (vi) possible disruptions from the proposed transaction that could harm Enzon’s or Viskase’s respective businesses; (vii) the ability of Viskase to retain, attract and hire key personnel; (viii) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (ix) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Enzon’s or Viskase’s financial performance; (x) certain restrictions during the pendency of the proposed transaction that may impact Enzon’s or Viskase’s ability to pursue certain business opportunities or strategic transactions; (xi) the exchange ratio and relative ownership levels as of the closing of the transactions contemplated by the Merger Agreement, as amended; (xii) estimates regarding future revenue, expenses, and capital requirements following the closing of the transactions contemplated by the Merger Agreement, as amended; (xiii) legislative, regulatory and economic developments; (xiv) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, trade wars, or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors; and (xv) such other risks and uncertainties, including those that are set forth in the Registration Statement under the heading “Risk Factors”, in Enzon’s periodic public filings with the SEC, and in Viskase’s annual and quarterly reports posted to Viskase’s website. Enzon and Viskase can give no assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, neither Enzon, nor Viskase undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

For Media Inquiries:
Richard L. Feinstein, CEO and CFO
Email: [email protected]

Brookdale Senior Living Inc. (BKD) Analyst/Investor Day Transcript

As I anticipated in my Q4 earnings preview, the story around Tesla, Inc.'s physical AI platform outweighed the fundamentals during the quarter. Q4 results showed auto revenue down 11% YOY, FCF down 30% YOY, and both GAAP and non-GAAP EPS down sharply YOY. That said, the Street consensus was overly pessimistic. Management is now accelerating autonomy and robotics, discontinuing Model S/X for Optimus production, and targeting 1M humanoid robots annually (long term).

, /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that, on January 21, 2026, the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase 1,600 shares of its common stock to one newly-hired employee under Nektar's 2025 Inducement Plan.

Nektar's 2025 Inducement Plan was adopted by its Board of Directors on November 6, 2025 and is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Nektar (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Nektar, pursuant to Nasdaq Listing Rule 5635(c)(4).

The stock options have an exercise price per share equal to $36.92, which is equal to the closing price of Nektar's common stock on January 21, 2026. The stock options have an eight-year term and will vest over four years with 1/4th of the shares vesting on the one-year anniversary of the employee's grant date and 1/48th of the shares vesting monthly thereafter over the next three years, subject to each employee's continued employment with Nektar on such vesting dates. The stock options are subject to the terms and conditions of Nektar's 2025 Inducement Plan, and the terms and conditions of the stock option agreement covering the grant.

About Nektar Therapeutics

Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in two Phase 2b clinical trials, one in atopic dermatitis, one in alopecia areata, and in one Phase 2 clinical trial in Type 1 diabetes mellitus. Nektar's pipeline also includes a preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422. Nektar, together with various partners, is also evaluating NKTR-255, an investigational IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer, in several ongoing clinical trials.

Nektar is headquartered in San Francisco, California. For further information, visit www.nektar.com and follow us on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements which can be identified by words such as: "could," "develop," "evaluate," "address," "may" and similar references to future periods. Examples of forward-looking statements include, among others, statements regarding the therapeutic potential of, and future development plans for, rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422, and NKTR-255. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, among others: (i) our statements regarding the therapeutic potential of rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422 and NKTR-255 are based on preclinical and clinical findings and observations and are subject to change as research and development continue; (ii) rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422 and NKTR-255 are investigational agents and continued research and development for these drug candidates is subject to substantial risks, including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166, NKTR-422 and NKTR-255 are in clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval; (iv) data reported from ongoing clinical trials are necessarily interim data only and the final results will change based on continuing observations; (v) the timing of the commencement or end of clinical trials and the availability of clinical data may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (vi) a Fast Track designation does not increase the likelihood that rezpegaldesleukin will receive marketing approval in the United States; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (viii) certain other important risks and uncertainties set forth in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contacts:

For Investors:

Vivian Wu
[email protected]

Corey Davis, Ph.D.
LifeSci Advisors, LLC
[email protected]
212-915-2577

Ahu Demir, Ph.D.
LifeSci Advisors, LLC
[email protected]
212-915-3820

For Media:

Jonathan Pappas
LifeSci Communications
857-205-4403
[email protected]

SOURCE Nektar Therapeutics

Warehouses De Pauw SA (WDPSF) Q4 2025 Earnings Call Transcript

CaixaBank, S.A. (CAIXY) Q4 2025 Earnings Call January 30, 2026 3:00 AM EST

Company Participants

Marta Noguer - Head of Investor and Shareholder Relations
Gonzalo Gortázar Rotaeche - CEO & Executive Director
Matthias Bulach - Head of Accounting, Mgmt Control & Capital

Conference Call Participants

Antonio Reale - BofA Securities, Research Division
Ignacio Ulargui - BNP Paribas, Research Division
Maksym Mishyn - JB Capital Markets, Sociedad de Valores, S.A., Research Division
Francisco Riquel - Alantra Equities Sociedad de Valores, S.A., Research Division
Cecilia Romero Reyes - Barclays Bank PLC, Research Division
Sofie Caroline Peterzens - Goldman Sachs Group, Inc., Research Division
Alvaro de Tejada - Morgan Stanley, Research Division
Marta Sánchez Romero - JPMorgan Chase & Co, Research Division
Ignacio Cerezo Olmos - UBS Investment Bank, Research Division
Andrea Filtri - Mediobanca - Banca di credito finanziario S.p.A., Research Division
Borja Ramirez Segura - Citigroup Inc., Research Division
Miruna Chirea - Jefferies LLC, Research Division
Lento Tang

Presentation

Marta Noguer
Head of Investor and Shareholder Relations

Good morning, and welcome to CaixaBank results presentation for the fourth quarter and the full year 2025. We are joined today by our CEO, Gonzalo Gortazar; and by Matthias Bulach, our Chief Accounting Management Control and Capital Officer, who also sits at the Management Committee. Our CFO, Javier Pano, is temporarily away on sick leave, but he's recovering well and expected to return shortly.

In terms of logistics, same as usual, we plan to spend about 30 minutes with the presentation and about 45 minutes to 1 hour with the Q&A. The Q&A is live, and you should have received instructions by e-mail on how to participate. Needless to say, my team and I will be at your full disposal after the call. And without further ado, Gonzalo, the floor is yours.

Gonzalo Gortázar Rotaeche
CEO & Executive Director

Thank you, Marta, and good morning, everybody. Thanks for taking the time. And

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Dryden Gold Corp. (TSXV: DRY) (OTCQB: DRYGF) (FSE: X7W) ("Dryden Gold" or the "Company is pleased to announce that it has closed (the "Closing") its previously announced (January 8, 2026, January 9, 2026) upsized non-brokered equity financing (the "Upsized Offering"). The Upsized Offering was comprised of 4,350,000 charity flow-through common shares (the "CFT Shares") at a price of $0.425 per CFT Share for aggregate gross proceeds of $1,848,750.

The CFT Shares will qualify as "flow-through shares", as defined in subsection 66(15) of the Income Tax Act (Canada) (the "Tax Act") and "Ontario focused flow-through shares", as defined in subsection 103(7) of the Taxation Act, 2007 (Ontario) ("Ontario Tax Act"). No finders' fees were paid in connection with the Upsized Offering.

An amount equal to the gross proceeds from the issuance of the CFT Shares will be used to incur eligible resource exploration expenses which will qualify as (i) "Canadian exploration expenses", as defined in subsection 66.1(6) of the Tax Act, (ii) provided Bill C-15, Budget 2025 Implementation Act, No. 1 receives Royal Assent, as "flow-through mining expenditures" as defined in subsection 127(9) of the Tax Act, and (iii) for certain Ontario purchasers, as "eligible Ontario exploration expenditures", as defined in subsection 103(4) of the Ontario Tax Act ("Qualifying Expenditures"). All Qualifying Expenditures will be renounced in favor of the subscribers for the CFT Shares effective on or before December 31, 2026.

The issuance of the shares under the offering remains subject to the final acceptance by the TSX Venture Exchange (the "TSXV") and compliance with applicable regulatory requirements including requirements under National Instrument 45-106 - Prospectus Exemptions ("NI 45-106").

ABOUT DRYDEN GOLD CORP.

Dryden Gold Corp. is an exploration company focused on the discovery of high-grade gold mineralization listed on the TSX Venture Exchange ("DRY"), on the OTCQB marketplace ("DRYGF") and on the FSE: ("X7W "). The Company has a strong management team and Board of Directors comprised of experienced individuals with a track record of building shareholder value through property acquisition and consolidation, exploration success, and mergers and acquisitions. Dryden Gold controls a 100% interest in a dominant strategic land position in the Dryden District of Northwestern Ontario. Dryden Gold's property package includes historic gold mines but has seen limited modern exploration. The property hosts high-grade gold mineralization over 50km of potential strike length along the Manitou-Dinorwic deformation zone. The property has excellent infrastructure, enjoys collaborative relationships with First Nations communities and benefits from proximity to an experienced mining workforce.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements
The information contained herein contains "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: receipt of corporate and regulatory approvals, issuance of common shares; future development plans; and the business and operations of Dryden Gold. Forward-looking statements relate to information that is based on assumptions of management, forecasts of future results, and estimates of amounts not yet determinable. Any statements that express predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be "forward-looking statements." Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation: risks related to failure to obtain adequate financing on a timely basis and on acceptable terms; political and regulatory risks associated with mining and exploration; risks related to the maintenance of stock exchange listings including receipt of TSX Venture Exchange approval for the offering; risks related to environmental regulation and liability; the potential for delays in exploration or development activities; the uncertainty of profitability; risks and uncertainties relating to the interpretation of drill results, the geology, grade and continuity of mineral deposits; risks related to the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses; the possibility that future exploration, development or mining results will not be consistent with the Company's expectations; risks related to commodity price fluctuations; and other risks and uncertainties related to the Company's prospects, properties and business detailed elsewhere in Dryden Gold's and the Company's disclosure record. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements. Investors are cautioned against attributing undue certainty to forward--looking statements. These forward-looking statements are made as of the date hereof and Dryden Gold and the Company do not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from Dryden Gold's and the Company's expectations or projections.

UNITED STATES ADVISORY. The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), have been offered and sold outside the United States to eligible investors pursuant to Regulation S promulgated under the U.S. Securities Act, and may not be offered, sold, or resold in the United States or to, or for the account of or benefit of, a U.S. Person (as such term is defined in Regulation S under the United States Securities Act) unless the securities are registered under the U.S. Securities Act, or an exemption from the registration requirements of the U.S. Securities Act is available. Hedging transactions involving the securities must not be conducted unless in accordance with the U.S. Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in the state in the United States in which such offer, solicitation or sale would be unlawful.

NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION INTO THE USA

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282245

Source: Dryden Gold Corp.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

ELMER, N.J.--(BUSINESS WIRE)--ELMER BANCORP, INC. (“Elmer Bancorp” or the “Company”) (OTCID: ELMA), the parent company of The First National Bank of Elmer (the “Bank”), announces its operating results for the fourth quarter and full year ended December 31, 2025.

For the three months ended December 31, 2025, Elmer Bancorp reported net income of $718,000, or $0.63 per common share compared to $715,000, or $0.63 per common share for the quarter ended December 31, 2024. For the twelve months ended December 31, 2025, net income totaled $3.302 million, or $2.89 per common share compared to $2.851 million, or $2.50 per common share for the twelve months ended December 31, 2024.

Net interest income for the three months ended December 31, 2025 totaled $4.036 million, an increase of $337,000 from the three months ended December 31, 2024 total of $3.699 million. This increase in net interest income is the result of higher interest and fees on loans and higher income on our overnight investments partially offset by higher interest paid on deposits. For the twelve months ended December 31, 2025, net interest income totaled $15.928 million, an increase of $1.343 million from the twelve months ended December 31, 2024 total of $14.585 million. This increase in net interest income for the twelve-month period results from higher interest and fees on loans resulting from core loan growth year-over-year partially offset by lower interest income on our overnight investments and higher interest paid on deposits. The loan loss provision was increased by $33,000 in the fourth quarter of 2025 and increased by $156,000 for the twelve months ended December 31, 2025 compared to an increase of $20,000 in the fourth quarter of 2024 and a decrease of $47,000 for the twelve months ended December 31, 2024. The variances in the loan loss provision are the result of the required loan loss calculation under the Current Expected Credit Loss (“CECL”) model. The allowance for loan losses was 1.27% of total core loans at December 31, 2025 compared to 1.28% of total core loans at December 31, 2024.

Non-interest income for the three months ended December 31, 2025 was $30,000 higher than the same three-month period a year ago and $627,000 higher than the twelve-month period last year. Increases in the cash surrender value of Bank Owned Life Insurance (“BOLI”) and increases in service fee income accounted for the increase in the three-month period. For the increase in the twelve-month period, the one-time BOLI payout of $530,000, higher service fee income and increased Visa credit card commissions were partially offset by no loss on Other Real Estate Owned (“OREO”).

Non-interest expenses for the three months ended December 31, 2025 were $355,000 higher than the same three-month period a year ago and $1.361 million higher than the twelve-month period last year. For the three-month period, the increase was the result of increases in employment costs, professional fees and other operating costs partially offset by a decrease in OREO expenses. For the twelve-month period, the increase was the result of higher employment costs, professional fees and occupancy and equipment expenses partially offset by lower OREO expenses.

Elmer Bancorp’s total assets at December 31, 2025 totaled $409.4 million, an increase of $28.7 million from the December 31, 2024 level of $380.7 million. Excluding $6.5 million in overnight funds from a large temporary deposit in December 2025, total core assets increased $22.2 million. Total loans were $327.3 million at December 31, 2025, an increase of $12.9 million from the December 31, 2024 total of $314.4 million. In addition, overnight investments increased $16.2 million.

Deposits totaled $367.9 million at December 31, 2025, an increase of $24.4 million from the December 31, 2024 level of $343.5 million. Excluding the December 31, 2025 large temporary deposit of $6.5 million, total core deposits increased $17.9 million. The positive variance from December 31, 2024 resulted from increases in certificates of deposit ($13.3 million), money market accounts ($7.3 million), demand deposits ($4.2 million) and interest-bearing checking accounts ($2.3 million) partially offset by decreases in savings deposits ($2.3 million) and IRA accounts ($847,000). This increase in deposits is the result of a money market and CD promotion to obtain new deposits. The Bank will continue to evaluate the current deposit environment and adjust, as appropriate, to maintain its strong deposit base. Stockholders’ equity totaled $39.1 million at December 31, 2025 compared to $35.4 million at December 31, 2024, an increase of $3.7 million. Elmer Bancorp’s book value per common share at December 31, 2025 was $33.91 per share compared to $30.91 per share at December 31, 2024. The Company and the Bank met all regulatory capital requirements at December 31, 2025.

Brian W. Jones, President and Chief Executive Officer, commented, “We are very pleased to report record net income of $3.302 million for year-end 2025 driven primarily by strong loan and deposit growth. Our total assets crossed the $400 million threshold reaching $409.4 million in the fourth quarter of 2025. Total loans increased $12.9 million to $327.3 million or 4.1%. Core deposit growth was $17.9 million or an increase of 5.2%. Our Loan Production Office (“LPO”) in Marlton continues to produce excellent results and support our client base in Burlington and Camden Counties. It was also a year of advancement in our service and product offerings, such as Positive Pay for business accounts, our new True Grow account and a new Instagram presence. As we look forward to 2026, I would like to thank our loyal customer base, our outstanding team members and our Board of Directors for their ongoing support.”

Chairman, P. Scott Boyer, stated, “I want to thank all of our employees for their dedication and hard work that resulted in 2025 being the best year in our Bank's history.”

The First National Bank of Elmer, a nationally chartered bank headquartered in Elmer, New Jersey, has a long history of serving the community since its beginnings in 1903. We are a community bank focused on providing deposit and loan products to retail customers and to small and mid-sized businesses from our six full-service branch offices located in Cumberland, Gloucester and Salem Counties, New Jersey, including our main office located at 10 South Main Street in Elmer, New Jersey. In addition to our branch offices, the bank also operates a loan production office (“LPO”) located in Marlton, NJ to service our clients in Burlington County. Deposits at The First National Bank of Elmer are insured up to the legally maximum amount by the Federal Deposit Insurance Corporation (FDIC).

For more information about Elmer Bank and its products and services, please visit our website at www.ElmerBank.com or call toll free 1-877-358-8141.

Forward-Looking Statements

This press release and other statements made from time to time by the Company’s management contain express and implied statements relating to our future financial condition, results of operations, credit quality, corporate objectives, and other financial and business matters, which are considered forward-looking statements. These forward-looking statements are necessarily speculative and speak only as of the date made, and are subject to numerous assumptions, risks and uncertainties, all of which may change over time. Actual results could differ materially from those expected or implied by such forward-looking statements. Risks and uncertainties which could cause our actual results to differ materially and adversely from such forward-looking statements include economic conditions affecting the financial industry: changes in interest rates and shape of the yield curve, credit risk associated with our lending activities, risks relating to our market area, significant real estate collateral and the real estate market, operating, legal and regulatory risk, fiscal and monetary policy, economic, political and competitive forces affecting our business, our ability to identify and address cyber-security risks, and management’s analysis of these risks and factors being incorrect, and/or the strategies developed to address them being unsuccessful. Any statements made that are not historical facts should be considered forward-looking statements. You should not place undue reliance on any forward-looking statements. We undertake no obligation to update forward-looking statements or to make any public announcement when we consider forward-looking statements to no longer be accurate, whether as a result of new information of future events, except as may be required by applicable law or regulation.

ELMER BANCORP, INC. AND SUBSIDIARIES SELECTED FINANCIAL DATA (unaudited)   Twelve Months Ended

Three Months Ended

12/31/2025

12/31/2024

12/31/2025

9/30/2025

6/30/2025

3/31/2025

Statement of Income Data: (dollars in thousands, except per share data)   Interest income $

20,429

$

18,270

$

5,231

$

5,293

$

5,151

$

4,754

Interest expense 4,501

3,685

1,195

1,182

1,150

973

Net interest income 15,928

14,585

4,036

4,111

4,001

3,781

Provision for loan losses 156

(47

)

33

40

44

40

Net interest income after provision for loan losses 15,772

14,632

4,003

4,071

3,957

3,741

Non-interest income 1,720

1,093

316

298

287

818

Non-interest expense 13,232

11,871

3,355

3,334

3,249

3,293

Income before income tax expense 4,260

3,854

964

1,035

995

1,266

Income tax expense 958

1,003

246

267

258

187

Net income $

3,302

$

2,851

$

718

$

768

$

737

$

1,079

  Earnings per share: Basic $

2.89

$

2.50

$

0.63

$

0.67

$

0.64

$

0.94

Diluted $

2.89

$

2.50

$

0.63

$

0.67

$

0.64

$

0.94

Weighted average basic shares outstanding 1,143,927

1,141,063

1,145,841

1,144,985

1,144,142

1,144,914

Weighted average diluted shares outstanding 1,144,200

1,141,661

1,146,570

1,145,490

1,144,423

1,146,095

Book value per share $

33.91

$

30.91

$

33.91

$

33.36

$

32.44

$

31.86

  Statement of Condition Data (Period End): 12/31/2025

12/31/2024

12/31/2025

9/30/2025

6/30/2025

3/31/2025

  Cash & due from banks $

46,422

$

30,246

$

46,422

$

51,203

$

47,293

$

29,774

Total investments 23,223

23,053

23,223

23,246

23,150

23,173

Total gross loans 327,269

314,365

327,269

323,248

322,262

320,385

Allowance for loan losses (4,162

)

(4,035

)

(4,162

)

(4,122

)

(4,077

)

(4,030

)

Accrued interest receivable 1,019

949

1,019

1,006

958

937

Premises & equipment, net 3,722

3,764

3,722

3,764

3,796

3,821

Other real estate owned -

1,134

-

-

-

-

Bank owned life insurance 8,848

8,101

8,848

8,774

7,703

7,641

Other assets 3,078

3,148

3,078

3,039

3,496

3,217

Total assets $

409,419

$

380,725

$

409,419

$

410,158

$

404,581

$

384,918

  Total deposits $

367,905

$

343,459

$

367,905

$

369,217

$

365,275

$

346,048

Accrued interest payable 252

190

252

235

178

149

Other liabilities 2,212

1,693

2,212

2,278

1,756

2,021

Total liabilities $

370,369

$

345,342

$

370,369

$

371,730

$

367,209

$

348,218

Total stockholders' equity $

39,050

$

35,383

$

39,050

$

38,428

$

37,372

$

36,700

Total liabilities & stockholders' equity $

409,419

$

380,725

$

409,419

$

410,158

$

404,581

$

384,918

More News From Elmer Bancorp, Inc.

WEST PALM BEACH, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Onity Group Inc. (NYSE: ONIT) (“Onity”) today announced that its subsidiaries, PHH Corporation and PHH Escrow Issuer LLC (the “Issuers”), closed their previously announced offering of 9.875% Senior Notes due 2029 (the “PHH Senior Notes”) in an aggregate principal amount of $200 million.

Glen A. Messina, Chair, President and CEO of Onity Group, said, “We opportunistically executed this debt offering to expand and strengthen our capital structure at attractive terms. We are pleased with the strong investor demand for this offering which reflects the continued confidence in our strategy and financial results. With an effective yield on this debt issuance of nearly 148 basis points lower than the original debt issuance in November 2024, we believe this transaction will provide greater financial flexibility to manage our leverage and invest in the growth of our business.”

The PHH Senior Notes were offered as an additional issuance of the Issuers’ 9.875% Senior Notes due 2029 and formed a single series of debt securities with the $500.0 million aggregate principal amount of such notes that were originally issued on November 6, 2024. The PHH Senior Notes were guaranteed on a senior secured basis by Onity and certain of PHH’s subsidiaries, including PHH Mortgage Corporation (“PMC”) and PHH Asset Services LLC (“PAS”).

The net proceeds from the offering will be used for general corporate purposes, including the repayment of mortgage servicing rights (MSR) indebtedness.

The PHH Senior Notes and the related guarantees were not and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction.

The PHH Senior Notes were sold only to persons reasonably believed to be qualified institutional buyers in reliance on the exemption from registration provided by Rule 144A of the Securities Act and to non-U.S. persons outside of the United States in compliance with Regulation S of the Securities Act.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer or sale of, any security in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Onity Group

Onity Group Inc. (NYSE: ONIT) is a leading non-bank financial services company providing mortgage servicing and originations solutions through its primary brands, PHH Mortgage and Liberty Reverse Mortgage. PHH Mortgage is one of the largest servicers in the country, focused on delivering a variety of servicing and lending programs to consumers and business clients. Liberty is one of the nation’s largest reverse mortgage lenders dedicated to providing loans that help customers meet their personal and financial needs. We are headquartered in West Palm Beach, Florida, with offices and operations in the United States, the U.S. Virgin Islands, India and the Philippines, and have been serving our customers since 1988.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by a reference to a future period or by the use of forward-looking terminology such as “will be” and references to goals, strategies, and agendas, although not all forward-looking statements contain these words. Forward-looking statements in this press release include statements relating to the debt issuance providing greater financial flexibility to manage leverage and invest in the growth of Onity’s business.

Forward-looking statements involve a number of assumptions, risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, but are not limited to, the timing for receipt of required consents to close our previously announced transaction with Finance of America Reverse LLC, the timing for receipt of required consents to transfer certain Rithm Capital Corp. (Rithm) assets, the size of the portfolio at the time of the Rithm transfer, Onity’s ability to restructure its operations in a timely and cost-effective manner in response to Rithm servicing transfers, Onity’s ability to identify and execute on alternative sources of revenue for its servicing business, Onity’s ability to adjust its liquidity management practices due to the reduction of servicing float balances associated with the Rithm agreements, the potential for ongoing disruption in the financial markets and in commercial activity generally as a result of U.S. and global political events, changes in monetary and fiscal policy, and other sources of instability; the impacts of inflation, employment disruption, and other financial difficulties facing our borrowers; the timing and amount of a release of the valuation allowance offsetting our net U.S. deferred tax asset; the adequacy of our financial resources, including our sources of liquidity and ability to sell, fund and recover servicing advances, forward and reverse whole loans, future draws on existing reverse loans, and HECM and forward loan buyouts and put backs, as well as repay, renew and extend borrowings, borrow additional amounts as and when required, meet our MSR or other asset investment objectives and comply with our debt agreements, including the financial and other covenants contained in them; our ability to interpret correctly and comply with current or future liquidity, net worth and other financial and other requirements of regulators, the Federal National Mortgage Association (Fannie Mae), and Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the GSEs), and the Government National Mortgage Association (Ginnie Mae); the impact of cost-reduction initiatives on our business and operations; the impact of our rebranding initiative; the amount of senior debt or common stock that we may repurchase under any repurchase programs, the timing of such repurchases, and the long-term impact, if any, of repurchases on the trading price of our securities or our financial condition; breach or failure of Onity’s, our contractual counterparties’, or our vendors’ information technology or other security systems or privacy protections, including any failure to protect customers’ data, resulting in disruption to our operations, loss of income, reputational damage, costly litigation and regulatory penalties; our reliance on our technology vendors to adequately maintain and support our systems, including our servicing systems, loan originations and financial reporting systems, and uncertainty relating to our ability to transition to alternative vendors, if necessary, without incurring significant cost or disruption to our operations; the extent to which MSR Asset Vehicle LLC (MAV) will exercise its rights to sell MSRs subserviced by PHH and the impact to our subservicing portfolio; our ability to close acquisitions of MSRs and other transactions, including the ability to obtain regulatory approvals; our ability to grow our reverse servicing business; our ability to retain clients and employees of acquired businesses, and the extent to which acquisitions and our other strategic initiatives will contribute to achieving our growth objectives; increased servicing costs based on increased borrower delinquency levels or other factors; uncertainty related to past, present or future claims, litigation, cease and desist orders and investigations regarding our servicing, foreclosure, modification, origination and other practices brought by government agencies and private parties, including state regulators, the Consumer Financial Protection Bureau (CFPB), State Attorneys General, the Securities and Exchange Commission (SEC), the Department of Justice or the Department of Housing and Urban Development (HUD); the reactions of key counterparties, including lenders, the GSEs and Ginnie Mae, to our regulatory engagements and litigation matters; increased regulatory scrutiny and media attention; any adverse developments in existing legal proceedings or the initiation of new legal proceedings; our ability to effectively manage our regulatory and contractual compliance obligations; our ability to comply with our servicing agreements, including our ability to comply with the requirements of the GSEs and Ginnie Mae and maintain our seller/servicer and other statuses with them; our ability to fund future draws on existing loans in our reverse mortgage portfolio; our servicer and credit ratings as well as other actions from various rating agencies, including any future downgrades; as well as other risks and uncertainties detailed in our reports and filings with the SEC, including our annual report on Form 10-K for the year ended December 31, 2024 and any current report or quarterly report filed with the SEC since such date. Onity’s forward-looking statements speak only as of the date they are made and Onity disclaims any obligation to update or revise forward-looking statements whether as a result of new information, future events or otherwise.

For Further Information Contact:

Investors:

Valerie Haertel, VP, Investor Relations
(561) 570-2969
[email protected]

Media:

Dico Akseraylian, SVP, Corporate Communications
(856) 917-0066
[email protected]

January 30, 2026 16:15 ET  | Source: Arbor Realty Trust

UNIONDALE, N.Y., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the tax treatment of its 2025 dividend distributions for common and preferred shares of beneficial interest.

For tax reporting purposes, 100% of the distributions paid on our common stock during 2025 will be classified as dividend income. The 2025 taxable distributions with respect to our common stock traded under ticker symbol ABR are summarized as follows:

           Common Shares (CUSIP #038923108)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution3/7/2025 3/21/2025 $0.43 $0.19 $0.24 $0.005/16/2025 5/30/2025 0.30 0.13 0.17 0.008/15/2025 8/29/2025 0.30 0.13 0.17 0.0011/14/2025 11/26/2025 0.30 0.13 0.17 0.00    $1.33 $0.58 $0.75 $0.00            The 2025 taxable distributions with respect to our 6.375% Series D Cumulative Redeemable Preferred Stock traded under ticker symbol ABR-PD are summarized as follows:

           6.375% Series D Cumulative Redeemable Preferred Stock (CUSIP #038923876)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution1/15/2025 1/30/2025 $0.398438 $0.178369 $0.220069 $0.004/15/2025 4/30/2025 0.398438 0.178369 0.220069 0.007/15/2025 7/30/2025 0.398438 0.178369 0.220069 0.0010/15/2025 10/30/2025 0.398438 0.178369 0.220069 0.00    $1.593750 $0.713475 $0.880275 $0.00            The 2025 taxable distributions with respect to our 6.25% Series E Cumulative Redeemable Preferred Stock traded under ticker symbol ABR-PE are summarized as follows:

           6.25% Series E Cumulative Redeemable Preferred Stock (CUSIP #038923868)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution1/15/2025 1/30/2025 $0.390625 $0.174871 $0.215754 $0.004/15/2025 4/30/2025 0.390625 0.174871 0.215754 0.007/15/2025 7/30/2025 0.390625 0.174871 0.215754 0.0010/15/2025 10/30/2025 0.390625 0.174871 0.215754 0.00    $1.562500 $0.699485 $0.863015 $0.00            The 2025 taxable distributions with respect to our 6.25% Series F Fixed to Floating Cumulative Redeemable Preferred Stock traded under ticker symbol ABR-PF are summarized as follows:

           6.25% Series F Fixed-to-Floating Cumulative Redeemable Preferred Stock (CUSIP #038923850)Record Date Payment Date Total Distribution Per Share Non-Qualified Dividend (1) Qualified Dividend Capital Gain Distribution1/15/2025 1/30/2025 $0.390625 $0.174871 $0.215754 $0.004/15/2025 4/30/2025 0.390625 0.174871 0.215754 0.007/15/2025 7/30/2025 0.390625 0.174871 0.215754 0.0010/15/2025 10/30/2025 0.390625 0.174871 0.215754 0.00    $1.562500 $0.699485 $0.863015 $0.00           (1) May be eligible for the 20% qualified business income deduction applicable to certain REIT dividends under IRC Section 199A(b)(1)(B).            For shareholders that may be required to report excess inclusion income to the Internal Revenue Service, we are pleased to report that in 2025, we will not pass through any excess inclusion income to our shareholders. As a result, no portion of the 2025 dividends should be treated as excess inclusion income for federal income tax purposes.

We do not issue K-1s to holders of our common and preferred stock. Please contact your financial advisor or broker to obtain information on a 1099 form.

Note: Shareholders are encouraged to consult with their tax advisors as to their specific tax treatment of our dividend distributions.

About Arbor Realty Trust, Inc.

Arbor Realty Trust, Inc. (NYSE: ABR) is a nationwide real estate investment trust and direct lender, providing loan origination and servicing for multifamily, single-family rental (SFR) portfolios, and other diverse commercial real estate assets. Headquartered in New York, Arbor manages a multibillion-dollar servicing portfolio, specializing in government-sponsored enterprise products. Arbor is a leading Fannie Mae DUS® lender and Freddie Mac Optigo® Seller/Servicer, and an approved FHA Multifamily Accelerated Processing (MAP) lender. Arbor’s product platform also includes bridge, CMBS, mezzanine and preferred equity loans. Rated by Standard and Poor’s and Fitch Ratings, Arbor is committed to building on its reputation for service, quality and customized solutions with an unparalleled dedication to providing our clients excellence over the entire life of a loan.

Safe Harbor Statement

Certain items in this press release may constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Arbor can give no assurance that its expectations will be attained. Factors that could cause actual results to differ materially from Arbor’s expectations include, but are not limited to, changes in economic conditions generally, and the real estate markets specifically, continued ability to source new investments, changes in interest rates and/or credit spreads, and other risks detailed in Arbor’s Annual Report on Form 10-K for the year ended December 31, 2024 and its other reports filed with the SEC. Such forward-looking statements speak only as of the date of this press release. Arbor expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Arbor’s expectations with regard thereto or change in events, conditions, or circumstances on which any such statement is based.

Contact:
Arbor Realty Trust, Inc.
Investor Relations
516-506-4200
[email protected]

MIAMI, FL, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lafayette Digital Acquisition Corp. I (Nasdaq: ZKPU) (the “Company”) today announced that, commencing February 4, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units.

No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on The Nasdaq Global Market under the symbols “ZKP” and “ZKPW,” respectively. Those units not separated will continue to trade on The Nasdaq Global Market under the symbol “ZKPU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

The offering of the units was made only by means of a prospectus, copies of which may be obtained from BTIG, LLC, 65 East 55th Street, New York, New York 10022, Attn: Syndicate Department, or by email at [email protected]. A registration statement on Form S-1 (333-290473) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and was declared effective on January 8, 2026. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Lafayette Digital Acquisition Corp. I

Lafayette Digital Acquisition Corp. I is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination in any sector, the Company will primarily focus on target businesses in the technology industry. The Company’s management team is led by Samuel A. Jernigan IV, its Chief Executive Officer and Chairman of the Board of Directors.

Cautionary Note Concerning Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the registration statement and the prospectus filed in connection with the initial public offering with the SEC. Copies are available on the SEC’s website, www.sec.gov.

Contact Information

Samuel A. Jernigan IV
Chief Executive Officer
[email protected]

, /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, today announced that the Company received a letter from the Nasdaq Listing Qualifications (the "Letter"), indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

Further, the Nasdaq Listing Rules also provide the Company a compliance period of 180 calendar days to regain compliance. According to the Letter, the Company has from January 29, 2026, or until July 28, 2026, to regain compliance with the minimum bid price requirement. The Company can regain compliance, if at any time during this 180 day period, the closing bid price of its ordinary shares is at least $1 for a minimum of ten consecutive business days, in which case the Company will be provided with a written confirmation of compliance and this matter will be closed. In the event the Company does not regain compliance after the initial 180-day period, the Company may then be eligible for an additional time if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period.

If the Company cannot demonstrate compliance by the end of the 180-day period, the Nasdaq's staff will notify the Company that its ordinary shares are subject to delisting.

The Letter has no immediate effect on the Company's Nasdaq listing or the trading of its ordinary shares, and during the grace period, as may be extended, Galmed's ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol "GLMD".

About Galmed Pharmaceuticals Ltd.

We are a biopharmaceutical company focused on the development of Aramchol. We have focused almost exclusively on developing Aramchol for the treatment of liver diseases, and continue to actively advance Aramchol for the treatment of combination therapy for NASH. We are also seeking to develop Aramchol for certain oncological indications outside of NASH and fibrosis. In addition, as part of our growth strategy, we are actively pursuing opportunities to expand and diversify our product pipeline specifically targeting cardiometabolic indications and other innovative product candidates that align with our core expertise in drug development.

Forward-Looking Statements

Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. For example, the Company is using forward-looking statements when it discusses regaining compliance with Nasdaq's continued listing requirements, and timing and effect thereof. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to the potential synergistic effect of Aramchol, Stivarga® and Metformin as a new fixed-dose combination treatment, the expected timing of clinical trials, future clinical development and creating value for investors and stakeholders. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the development and approval of the use of Aramchol or any other product candidate for indications outside of non-alcoholic steatohepatitis, or NASH, also known as metabolic dysfunction-associated steatohepatitis, or MASH, and fibrosis or in combination therapy; the timing and cost of any pre-clinical or clinical trials of Aramchol or any other product candidate we develop; completion and receiving favorable results of any pre-clinical or clinical trial; regulatory action with respect to Aramchol or any other product candidate by the U.S. Food and Drug Administration, or the FDA, or the European Medicines Authority, or EMA, including but not limited to acceptance of an application for marketing authorization, review and approval of such application, and, if approved, the scope of the approved indication and labeling; the commercial launch and future sales of Aramchol and any future product candidates; our ability to comply with all applicable post-market regulatory requirements for Aramchol, or any other product candidate in the countries in which we seek to market the product; our ability to achieve favorable pricing for Aramchol, or any other product candidate; third-party payor reimbursement for Aramchol, or any other product candidate; our estimates regarding anticipated capital requirements and our needs for additional financing; market adoption of Aramchol or any other product candidate by physicians and patients; the timing, cost or other aspects of the commercial launch of Aramchol or any other product candidate; our ability to obtain and maintain adequate protection of our intellectual property; the possibility that we may face third-party claims of intellectual property infringement; our ability to manufacture our product candidates in commercial quantities, at an adequate quality or at an acceptable cost; our ability to establish adequate sales, marketing and distribution channels; intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; our expectations regarding licensing, acquisitions and strategic operations; current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk; our ability to maintain the listing of our ordinary shares on The Nasdaq Capital Market; the security, political and economic instability in the Middle East that could harm our business, including due to the current security situation in Israel, risks relating to our digital asset management strategy, including the highly volatile nature of the price of cryptocurrencies and other digital assets, the risk that our share price may be highly correlated to the price of the cryptocurrencies and other digital assets that we may hold, risks related to increased competition in the industries in which we do and will operate, risks relating to significant legal, commercial, regulatory and technical uncertainty regarding cryptocurrencies and other digital assets generally, risks relating to the treatment of crypto assets for U.S. and foreign tax purposes and those risks and uncertainties identified in Exhibit 99.2 to our Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission ("SEC") on August 25, 2025. We believe these forward-looking statements are reasonable; however, these statements are only current predictions and are subject to known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements. We discuss many of these risks in our Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on April 2, 2025 in greater detail under the heading "Risk Factors." Given these uncertainties, you should not rely upon forward-looking statements as predictions of future events. All forward-looking statements attributable to us or persons acting on our behalf speak only as of the date hereof and are expressly qualified in their entirety by the cautionary statements included in this report. We undertake no obligations to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking statements, you should consider these risks and uncertainties.

Logo - https://mma.prnewswire.com/media/1713483/Galmed_Pharmaceuticals_Logo.jpg

SOURCE Galmed Pharmaceuticals Ltd.

, /PRNewswire/ -- The Trustees of North European Oil Royalty Trust (NYSE-NRT) announced today a quarterly distribution of $0.22 per unit for the first quarter of fiscal 2026, payable on February 25, 2026 to owners of record on February 13, 2026.  This compares to a distribution of $0.04 per unit for the first quarter of fiscal 2025.

In accordance with the agreements between the Trust and the operating companies, the Trust's monthly scheduled royalty payments are paid based on the amount of royalties that were payable to the Trust in the prior calendar quarter.  Adjustments to the scheduled payments occur when scheduled payments differ from actual results. The significant increase in the year-over-year first quarter distribution results primarily from the lack of negative adjustments. The remaining balance of the negative adjustments from calendar 2023 totaling $1,754,661 impacted the 2025 first quarter distribution.  For the first quarter of fiscal 2026, there were positive end-of-quarter adjustments of $30,820 and $51,072 and a positive Mobil sulfur payment of $79,183. Further details will be available in the 10-Q scheduled to be released on or about February 27, 2026.

The cumulative 12-month distribution, which includes the January 2026 distribution and the three prior quarterly distributions, is $0.99 per unit. This 12-month cumulative distribution is 111%, or $0.52 per unit, higher than the prior 12-month distribution of $0.47 per unit.  The Trust makes quarterly distributions to unit owners during the months of February, May, August, and November.

Contact – Nancy J. Floyd Prue, Managing Trustee, telephone: (732) 741-4008, email: [email protected]. The Trust's press releases and other pertinent information are available on the Trust's website: www.neort.com.

Forward-Looking Statements

This press release may contain forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements address future expectations and events or conditions concerning the Trust, such as statements concerning future gas prices, royalty payments, and cash distributions. Many of these statements are based on information provided to the Trust by the operating companies or by consultants using public information sources, are difficult to predict, and are generally beyond the control of the Trust.  These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements. These include: the fact that the assets of the Trust are depleting assets and, if the operators developing the concession do not perform additional development projects, the assets may deplete faster than expected; risks and uncertainties concerning levels of gas production and gas sale prices, general economic conditions, and currency exchange rates; the ability or willingness of the operating companies to perform under their contractual obligations with the Trust; potential disputes with the operating companies and the resolution thereof; and political and economic uncertainty arising from Russia's invasion of Ukraine.  Any forward-looking statement speaks only as of the date on which such statement is made, and the Trust does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

SOURCE North European Oil Royalty Trust